Adverse effects of beta-blocker therapy for patients with heart failure: a quantitative overview of randomized trials.
暂无分享,去创建一个
H. Krumholz | J. Curtis | C. Coffey | J. Foody | P. Hebert | A. Sedrakyan | D. Ko
[1] P. O'Malley. Review: β blockers reduce mortality and therapy withdrawal in heart failure but increase dizziness and bradycardia , 2005, ACP journal club.
[2] M. Bristow. β-Adrenergic Receptor Blockade in Chronic Heart Failure , 2000 .
[3] J. Ornato,et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article , 2005 .
[4] J. A. Bowers,et al. Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group. , 1996, Circulation.
[5] D. DeMets,et al. Effect of carvedilol on survival in severe chronic heart failure. , 2001, The New England journal of medicine.
[6] A. Hoes,et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. , 2005, European heart journal.
[7] D. Baker,et al. Management of heart failure. I. Pharmacologic treatment. , 1994, JAMA.
[8] K. Swedberg,et al. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy , 1993, The Lancet.
[9] K. Adams,et al. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators. , 1996, Circulation.
[10] Lawrence Joseph,et al. β-Blockers in Congestive Heart Failure: A Bayesian Meta-Analysis , 2001 .
[11] R Dietz,et al. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. , 2000, JAMA.
[12] Milton Packer,et al. Safety and efficacy of carvedilol in severe heart failure , 1997 .
[13] M. Gheorghiade,et al. Practical aspects of using beta-adrenergic blockade in systolic heart failure. , 2001, The American journal of medicine.
[14] E. Braunwald. Heart Disease: A Textbook of Cardiovascular Medicine , 1992, Annals of Internal Medicine.
[15] H. Sacks,et al. Early or Deferred Zidovudine Therapy in HIV-Infected Patients without an AIDS-Defining Illness , 1995, Annals of Internal Medicine.
[16] J. Cohn,et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. , 1996, The New England journal of medicine.
[17] Nick Freemantle,et al. β Blockade after myocardial infarction: systematic review and meta regression analysis , 1999 .
[18] Eric J. Eichhorn. Prognosis determination in heart failure. , 2001, The American journal of medicine.
[19] L. Stevenson,et al. Medical management of advanced heart failure. , 2002, JAMA.
[20] S. Gottlieb,et al. Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise. , 1996, Circulation.
[21] W. Abraham. Beta-blockers: the new standard of therapy for mild heart failure. , 2000, Archives of internal medicine.
[22] E. Braunwald,et al. Beta-adrenergic receptor blocking drugs. Mechanisms of action and clinical applications. , 1966, The New England journal of medicine.
[23] R. Califf,et al. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). , 1996, Journal of the American College of Cardiology.
[24] G Cooper,et al. Bradycardia and the role of beta-blockade in the amelioration of left ventricular dysfunction. , 2000, Circulation.